COVID-19 and immunomodulation treatment for women with reproductive failures
Authors:
Lenka Sedláčková
Authors‘ workplace:
Oddělení alergologie a klinické imunologie, GENNET, s. r. o., Praha
Published in:
Čas. Lék. čes. 2021; 160: 33-36
Category:
Review Article
Overview
COVID-19 pandemic is affecting various areas of health care, including reproductive medicine. Many women with infertility are treated by immunomodulation and immunosuppression in periimplantation period due to underlying autoimmune diseases or cellular immune dysfunction. Many questions have been raised in relation to COVID-19, including susceptibility to SARS-CoV-2 infection in women with immunotherapy, how to manage women with an increased risk of and active COVID-19 infection. International team of reproductive immunologists led by professor Joanne Kwak-Kim prepared a review of information and recommendations for using immunotherapy in women with reproductive disorder in COVID-19 pandemic. Everyday practice need led us to presentation of the synopsis of these interim guidelines for particular treatment modalities.
Keywords:
COVID-19 – SARS-CoV-2 – immunotherapy – reproductive failure – pregnancy
Sources
- Schwartz DA. An analysis of 38 pregnant women with covid-19, their newborn infants, and maternal-fetal transmission of sars-cov-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020, doi: 10.5858/arpa.2020-0901-SA.
- Naves do Amaral W, Leão de Moraes C, Dos Santos Rodrigues AP et al. Maternal coronavirus infections and neonates born to mothers with SARS-CoV-2: a systematic review. Healthcare (Basel) 2020; 8(4): 511.
- Kwak-Kim J, Ota K, Sung N et al. COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 2020; 141: 103168.
- Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012; 6: CD005996.
- Lédée N, Prat-Ellenberg L, Petitbarat M et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J Reprod Immunol 2018; 127: 11–15.
- Cao W, Liu X, Bai T et al. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open Forum Infect Dis 2020; 7: ofaa102.
- COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health, 2021 Mar 5. Dostupné na: www.covid19treatmentguidelines.nih.gov
- Pathak DSK, Salunke DAA, Thivari DP et al. No benefit of hydroxychloroquine in COVID-19: results of systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2020; 14: 1673-1680.
- D’Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl 2020; 26: 832-834.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
2021 Issue 1
Most read in this issue
- Circulating NK and NKT cells in the diagnosis and treatment of immunological causes of female infertility – retrospective data analysis from the tertiary clinical center
- Current possibilities of diagnostics and treatment of immunological causes of female infertility
- Diagnostics of infertile males in the 21st century – a traditional concept or a modern approach?
- Conspiracy theories as a natural part of pandemics